1.55
price up icon1.31%   0.02
after-market Dopo l'orario di chiusura: 1.53 -0.02 -1.29%
loading
Precedente Chiudi:
$1.53
Aprire:
$1.54
Volume 24 ore:
121.57K
Relative Volume:
0.36
Capitalizzazione di mercato:
$66.48M
Reddito:
$51.13M
Utile/perdita netta:
$-93.80M
Rapporto P/E:
-0.6951
EPS:
-2.23
Flusso di cassa netto:
$-129.10M
1 W Prestazione:
+1.97%
1M Prestazione:
+9.15%
6M Prestazione:
+27.05%
1 anno Prestazione:
-60.05%
Intervallo 1D:
Value
$1.5202
$1.5794
Intervallo di 1 settimana:
Value
$1.50
$1.5794
Portata 52W:
Value
$0.89
$4.22

Repare Therapeutics Inc Stock (RPTX) Company Profile

Name
Nome
Repare Therapeutics Inc
Name
Telefono
(857) 412-7018
Name
Indirizzo
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Name
Dipendente
129
Name
Cinguettio
@reparerx
Name
Prossima data di guadagno
2023-08-09
Name
Ultimi documenti SEC
Name
RPTX's Discussions on Twitter

Confronta RPTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RPTX
Repare Therapeutics Inc
1.55 65.62M 51.13M -93.80M -129.10M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-06-09 Aggiornamento Stifel Hold → Buy
2023-02-03 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-01-06 Iniziato CapitalOne Overweight
2022-04-12 Downgrade Stifel Buy → Hold
2022-03-17 Ripresa Goldman Buy
2021-09-23 Iniziato Stifel Buy
2021-09-13 Iniziato H.C. Wainwright Buy
2021-06-28 Iniziato Guggenheim Buy
2021-03-01 Iniziato Berenberg Buy
2020-10-28 Iniziato Northland Capital Outperform
2020-07-14 Iniziato Cowen Outperform
2020-07-14 Iniziato Goldman Neutral
2020-07-14 Iniziato Morgan Stanley Overweight
2020-07-14 Iniziato Piper Sandler Overweight
Mostra tutto

Repare Therapeutics Inc Borsa (RPTX) Ultime notizie

pulisher
Jul 24, 2025

Is Repare Therapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Why Repare Therapeutics Inc. stock is on top investor watchlistsUnrivaled growth potential - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Repare Therapeutics Inc. stock outlookMarket-leading growth rates - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Repare Therapeutics Inc. stock benefit from interest rate changesDynamic growth stocks - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Repare Therapeutics Inc. stock priceExponential return rates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Repare Therapeutics Inc. stockRecord-breaking gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Repare Therapeutics Inc. Stock Analysis and ForecastUnprecedented growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

what makes repare therapeutics inc. stock price move sharplyLow Risk Profit Ideas - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025
pulisher
Jul 16, 2025

Repare Therapeutics Jumps 15% After $10M Licensing Deal With Debiopharm - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

How Repare Therapeutics Inc. stock performs during market volatilityBig Profit Small Risk Alerts - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Repare Therapeutics Jumps 15% After $10M Licensing Deal With Deb - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Repare Therapeutics Licenses Lunresertib to Debiopharm for Worldwide Development. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Deal Watch: Debiopharm Takes On Precision Oncology Drug From Repare Collab - insights.citeline.com

Jul 16, 2025
pulisher
Jul 16, 2025

Repare inks licensing deal with Debiopharm for lunresertib - The Pharma Letter

Jul 16, 2025
pulisher
Jul 16, 2025

Repare Therapeutics Jumps After Hours On $267M Global Licensing Deal With Debiopharm; Retail Traders Rush In - Stocktwits

Jul 16, 2025
pulisher
Jul 16, 2025

how repare therapeutics inc. stock performs during market volatilityFast Moving Stock Alerts - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Repare Therapeutics' Lunresertib Deal: A Strategic Pivot to Unlock Oncology Potential and Near-Term Catalysts - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Repare Therapeutics stock surges after $10M licensing deal with Debiopharm By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Repare Therapeutics Inc. stock price move sharplyHigh Reward Risk Balanced Trading - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics stock surges after $10M licensing deal with Debiopharm - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics Inc. Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics (RPTX) Secures Global Licensing Deal with Debiopharm | RPTX Stock News - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics enters exclusive worldwide licensing agreement with Debiopharm for Lunresertib - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics licenses PKMYT1 inhibitor to Debiopharm for $10 million - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics jumps on cancer drug licensing deal - TradingView

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib | RPTX Stock News - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib - Business Wire

Jul 15, 2025

Repare Therapeutics Inc Azioni (RPTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):